Introduction and importance: Thornwaldt’s cysts are benign nasopharyngeal anomalies that are often asymptomatic but can present diagnostic challenges and potential complications, necessitating clinical vigilance. Although these cysts are typically benign, their incidental discovery requires careful evaluation, particularly in asymptomatic patients with co-morbid conditions such as chronic kidney disease (CKD). This case underscores the importance of comprehensive imaging and ongoing monitoring for proper management of such nasopharyngeal anomalies. Case presentation: We present the case of a 28-year-old man with CKD who was incidentally diagnosed with a Thornwaldt’s cyst while being evaluated for recurrent epistaxis and dizziness. Initial clinical examination revealed nasal turbinate hypertrophy but with normal nasal patency. Magnetic resonance imaging of the brain and nasopharynx revealed a clearly defined, small cystic mass (1.1 × 1.2 cm) located on the posterior nasopharyngeal wall. Clinical discussion: Thornwaldt’s cysts generally have a favorable prognosis with conservative management. However, periodic imaging and clinical evaluation are essential to detect any symptomatic progression or complications that may require surgical intervention. Although the cyst was relatively large in comparison to typical literature reports, its benign nature, along with the patient’s lack of symptoms, allowed for conservative management. Given the patient’s underlying CKD, close monitoring was recommended to detect any changes in size or potential complications, including the development of obstructive symptoms or infection. Conclusion: Diligent monitoring through routine imaging is crucial for detecting and managing incidental findings such as Thornwaldt’s cysts, especially in patients with underlying health conditions like CKD. Routine follow-ups are necessary to ensure early intervention if symptoms develop or if the cyst changes in size, ensuring timely management of any potential complications.
28 August 2024 in International Journal of Scientific Reports
Alzheimer’s disease is a comprehensive clinical syndrome featuring cognitive, emotional, and volitional function deterioration. Treatment strategies for Alzheimer's disease involve a mix of pharmacological and non-pharmacological approaches. Current treatments focus on palliative care with limited impact on the disease course. Venom-derived substances, known for their neuroactive properties, have emerged as a novel approach to Alzheimer's treatment. Our team conducted a thorough search for electronic literature related to therapeutic venom-derived substances efficacy in Alzheimer’s disease in different databases, including Medline, PubMed, Google Scholar, and Psych INFO, up to May 2024. In this article, the therapeutic effects of various venom-derived substances effects in Alzheimer’s disease are discussed. Various substances grant anti-inflammatory and anti-oxidant effects. The clinical application of venom-derived therapy is still a long way ahead, still, researchers believe that the ongoing work will eventually allow its compounds to be considered definitive candidates in various therapies in upcoming years.